Literature DB >> 10705024

Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: comparative measurements using EF5 binding and the Eppendorf needle electrode.

W T Jenkins1, S M Evans, C J Koch.   

Abstract

PURPOSE: The purpose of this study was to assess the presence of tumor hypoxia using two independent techniques: binding of the 2-nitroimidazole EF5 and Eppendorf needle electrode measurements. The distribution of tumor hypoxia was assessed with respect to tumor necrosis in corresponding histological studies. METHODS AND MATERIALS: Each of several rats bearing a subcutaneous 9L glioma or Morris 7777 hepatoma tumor was given EF5 i.v. to a final, whole-body concentration of 100 microM. About 2.5 h later, each rat was anesthetized, and needle electrode measurements were made in the tumor along 1-5 tracks (30-200 individual measurements). At 3 h post-EF5 injection, the tumor was excised and frozen. Frozen sections were analyzed for the presence and distribution of binding of EF5 and necrosis using immunohistochemical techniques followed by staining with hematoxylin and eosin (H&E). The histochemical analysis and electrode readings in similar regions of the tumor were compared.
RESULTS: Electrode measurements were taken at 0.4-mm intervals along one-dimensional tracks, whereas EF5 binding measurements from tissue sections contained two-dimensional information at high spatial resolution ( approximately 2.5 micro). The EF5 measurements showed greater spatial heterogeneity than did the electrode measurements. In tumor regions with minimal necrosis, needle tracks with relatively high pO(2) readings were usually found to contain relatively low EF5 binding, and vice versa. Because EF5 binding is inversely related to tissue pO(2), this result was expected. The expected inverse correlation of the two techniques was most disparate in necrotic tumor regions (confirmed by H&E staining), where needle electrode measurements showed low to zero pO(2) values, but little or no EF5 binding was found.
CONCLUSION: The two methods compared in this study operate in fundamentally different ways and provide substantially different information. EF5 binding provided detailed spatial information on the distribution of hypoxia in viable tumor tissue. There was no EF5 binding in necrotic tumor tissue because cells in such tissue were unable to metabolize the drug. In contrast, output from the needle electrode method appeared to represent a "track-average" tissue pO(2) and did not distinguish between extreme hypoxia and either macroscopic or microscopic necrosis. At the present time, the importance of tumor necrosis in determining treatment response is unknown. However, our data suggest that the Eppendorf needle electrode technique will overestimate the presence of hypoxia. Both techniques are potentially limited by sampling errors in tumors with heterogeneous distributions of hypoxia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10705024     DOI: 10.1016/s0360-3016(99)00342-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  16 in total

1.  Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.

Authors:  Narges K Tafreshi; Mark C Lloyd; Joshua B Proemsey; Marilyn M Bui; Jongphil Kim; Robert J Gillies; David L Morse
Journal:  Mol Imaging Biol       Date:  2016-04       Impact factor: 3.488

2.  Mechanisms of blood flow and hypoxia production in rat 9L-epigastric tumors.

Authors:  Cameron J Koch; W Timothy Jenkins; Kevin W Jenkins; Xiang Yang Yang; A Lee Shuman; Stephen Pickup; Caitlyn R Riehl; Ramesh Paudyal; Harish Poptani; Sydney M Evans
Journal:  Tumor Microenviron Ther       Date:  2013-01

3.  The radiation response of cells from 9L gliosarcoma tumours is correlated with [F18]-EF5 uptake.

Authors:  Cameron J Koch; Anne L Shuman; Walter T Jenkins; Alexander V Kachur; Joel S Karp; Richard Freifelder; William R Dolbier; Sydney M Evans
Journal:  Int J Radiat Biol       Date:  2009-12       Impact factor: 2.694

4.  In situ oxygen utilization in the rat intervertebral disc.

Authors:  Deanna C Lee; Christopher S Adams; Todd J Albert; Irving M Shapiro; Sydney M Evans; Cameron J Koch
Journal:  J Anat       Date:  2007-03       Impact factor: 2.610

5.  Tumor oxygen dynamics: correlation of in vivo MRI with histological findings.

Authors:  Dawen Zhao; Sophia Ran; Anca Constantinescu; Eric W Hahn; Ralph P Mason
Journal:  Neoplasia       Date:  2003 Jul-Aug       Impact factor: 5.715

6.  Preparation of chitosan-polyaspartic acid-5-fluorouracil nanoparticles and its anti-carcinoma effect on tumor growth in nude mice.

Authors:  Dan-Ying Zhang; Xi-Zhong Shen; Ji-Yao Wang; Ling Dong; Yong-Li Zheng; Li-Li Wu
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

Review 7.  The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities.

Authors:  Joseph C Walsh; Artem Lebedev; Edward Aten; Kathleen Madsen; Liane Marciano; Hartmuth C Kolb
Journal:  Antioxid Redox Signal       Date:  2014-05-09       Impact factor: 8.401

8.  Hypoxia in melanoma: using optical spectroscopy and EF5 to assess tumor oxygenation before and during regional chemotherapy for melanoma.

Authors:  Paul J Speicher; Georgia M Beasley; Betty Jiang; Michael E Lidsky; Gregory M Palmer; Peter M Scarbrough; Paul J Mosca; Mark W Dewhirst; Douglas S Tyler
Journal:  Ann Surg Oncol       Date:  2013-08-28       Impact factor: 5.344

Review 9.  Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases.

Authors:  Narges K Tafreshi; Mark C Lloyd; Marilyn M Bui; Robert J Gillies; David L Morse
Journal:  Subcell Biochem       Date:  2014

10.  (18)F-fluoromisonidazole positron emission tomography can predict pathological necrosis of brain tumors.

Authors:  Takuya Toyonaga; Kenji Hirata; Shigeru Yamaguchi; Kanako C Hatanaka; Sayaka Yuzawa; Osamu Manabe; Kentaro Kobayashi; Shiro Watanabe; Tohru Shiga; Shunsuke Terasaka; Hiroyuki Kobayashi; Yuji Kuge; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-02-03       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.